Related Experiment Video
Updated: May 20, 2026

In Vitro Directed Evolution of a Restriction Endonuclease with More Stringent Specificity
Published on: March 25, 2020
Endonuclease substrate selectivity characterized with full-length PA of influenza A virus polymerase
Erin Noble1, Andrew Cox, Jerome Deval
1Department of Microbiology and Immunology, University of Rochester, Rochester, NY 14642, USA.
Abstract:
The influenza A polymerase is a heterotrimer which transcribes viral mRNAs and replicates the viral genome. To initiate synthesis of mRNA, the polymerase binds a host pre-mRNA and cleaves a short primer downstream of the 5' end cap structure. The N-terminal domain of PA has been demonstrated to have endonuclease activity in vitro. Here we sought to better understand the biochemical nature of the PA endonuclease by developing an improved assay using full-length PA protein. This full-length protein is active against both RNA and DNA in a cap-independent manner and can use several different divalent cations as cofactors, which affects the secondary structure of the full-length PA. Our in vitro assay was also able to demonstrate the minimal substrate size and sequence selectivity of the PA protein, which is crucial information for inhibitor design. Finally, we confirmed the observed endonuclease activity of the full-length PA with a FRET-based assay.
Insights
The influenza A PA protein acts as an endonuclease, cleaving RNA and DNA. This study characterized its activity, revealing crucial details for designing new antiviral inhibitors.
Area of Science:
- Virology
- Molecular Biology
- Biochemistry
Background:
- Influenza A polymerase is essential for viral transcription and replication.
- The PA subunit's N-terminal domain exhibits endonuclease activity.
- Understanding PA endonuclease function is key for antiviral drug development.
Purpose of the Study:
- To biochemically characterize the endonuclease activity of full-length influenza A PA protein.
- To develop an improved assay for studying PA endonuclease function.
- To identify key properties of PA for inhibitor design.
Main Methods:
- Developed an improved in vitro assay using full-length PA protein.
- Assessed activity against RNA and DNA substrates.
- Investigated cofactor requirements (divalent cations) and substrate characteristics (size, sequence selectivity).
- Confirmed endonuclease activity using a FRET-based assay.
Main Results:
- Full-length PA protein exhibits cap-independent endonuclease activity on both RNA and DNA.
- Activity is modulated by divalent cations, influencing PA secondary structure.
- Determined the minimal substrate size and sequence selectivity of PA.
- Confirmed PA endonuclease activity in vitro.
Conclusions:
- The PA endonuclease is a versatile enzyme with RNA and DNA cleavage capabilities.
- Characterization provides critical insights into substrate requirements and cofactor dependency.
- Findings are vital for the rational design of influenza A antiviral inhibitors targeting PA.
More Related Videos
22:10Multi-target Parallel Processing Approach for Gene-to-structure Determination of the Influenza Polymerase PB2 Subunit
Published on: June 28, 2013
07:38DNA Polymerase Activity Assay Using Near-infrared Fluorescent Labeled DNA Visualized by Acrylamide Gel Electrophoresis
Published on: October 6, 2017
Related Concept Videos
Leaky Scanning
Eukaryotic RNA Polymerases
All three eukaryotic RNAPs require specific transcription factors, of which the...
Long-patch Base Excision Repair